Decreased plasma nesfatin-1 level is related to the thyroid dysfunction in patients with type 2 diabetes mellitus. - Wikidata - awgldk - TriplyDB

Decreased plasma nesfatin-1 level is related to the thyroid dysfunction in patients with type 2 diabetes mellitus.

Decreased plasma nesfatin-1 level is related to the thyroid dysfunction in patients with type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q33786737

about

Nesfatin-1 and its effects on different systems Association of the polymorphism in NUCB2 gene and the risk of type 2 diabetes.The effects of Nigella sativa on thyroid function, serum Vascular Endothelial Growth Factor (VEGF) - 1, Nesfatin-1 and anthropometric features in patients with Hashimoto's thyroiditis: a randomized controlled trial.Correlation of Brain Neuropeptide (Nesfatin-1 and Orexin-A) Concentrations with Anthropometric and Biochemical Parameters in Malnourished Children Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.High levels of Nesfatin-1 in relation to the dysfunction of the hypothalamic-pituitary-adrenal and hypothalamus-pituitary-thyroid axes in depressed patients with subclinical hypothyroidism.Circulating Nesfatin-1 Levels and Type 2 Diabetes: A Systematic Review and Meta-Analysis.Relation of serum and vitreous nesfatin-1 concentrations with diabetic retinopathy.Plasma nesfatin-1 level is associated with severity of depression in Chinese depressive patients.

P2860

Q26782243-87E9BB6C-7B62-463A-B3CF-17EEA5FAC805 Q33709075-56FEAB8E-4714-4721-A041-01C22BDF721C Q36194577-F609604E-0899-44B9-BB8F-A1713E7F9BBA Q36367777-86B748E1-990B-490F-8658-E91247623CEA Q37327751-BED9CAD1-BBB1-4C0E-91C8-11ECC8BB8D2D Q41000922-926B4D00-EBBD-48D0-B5A1-6856B81C9B4B Q49497444-DFB985F9-3E3C-44AA-8769-9F6955577FC1 Q51273929-C4F50255-00C9-4D96-BC19-0782A19AA3B6 Q55030878-F019F2DD-E650-480F-A352-1AE0A56B4358

P2860

Decreased plasma nesfatin-1 level is related to the thyroid dysfunction in patients with type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q33786737

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Decreased plasma nesfatin-1 le ...... with type 2 diabetes mellitus.

@ast

Decreased plasma nesfatin-1 le ...... with type 2 diabetes mellitus.

@en

type

label

Decreased plasma nesfatin-1 le ...... with type 2 diabetes mellitus.

@ast

Decreased plasma nesfatin-1 le ...... with type 2 diabetes mellitus.

@en

prefLabel

Decreased plasma nesfatin-1 le ...... with type 2 diabetes mellitus.

@ast

Decreased plasma nesfatin-1 le ...... with type 2 diabetes mellitus.

@en

P1433

Q33786737-DDAD0C69-7247-48AD-8095-9AA60ED5AEF3

P1476

Q33786737-3E71CB1D-F6AF-40B4-8CA2-8EEDDAD1B1CB

P2093

Q33786737-209F881B-8526-487A-B3E2-992753018760

Q33786737-BF6F2F93-E821-4462-8502-670D0E37C462

Q33786737-EA8711BC-20AC-4BDA-AE7B-65189E153FF3

Q33786737-FD4B8408-A48E-41E0-BF69-5EC6F948D4C1

P2860

Q33786737-02C43E08-98AB-41DC-86E2-62FBACFBD260

Q33786737-1813FE95-FE9D-4E4F-808B-747B18D7B6CA

Q33786737-3969DE50-5562-4A4E-A974-A628DE11B466

Q33786737-3BA94FD0-254C-447D-93D8-93CE663FFA00

Q33786737-51749D0B-AA5F-4380-BB1F-2511B6449B74

Q33786737-5F757E99-6613-4650-B84F-3C37763F4455

Q33786737-7AE09F81-A7A9-4A1E-B01D-031F5DF909D2

Q33786737-7D45651E-F068-43E0-9CCC-6D8496DE62C5

Q33786737-807DB55D-B603-496F-99C7-A30FA944030E

Q33786737-81CD990B-5066-49AA-AD41-DFDC74554D75

P304

Q33786737-2215649F-E10F-4F13-8AA0-F7F52E839D7E

P31

Q33786737-2F96F839-782A-4C3C-8226-C4387524A459

P356

Q33786737-8D0EF9C3-2C4E-4152-A074-09476ED2C08E

P478

Q33786737-17A6A52E-B34F-4028-BEE6-7BCEECDECCDB

P50

Q33786737-EE92BBEB-5665-4554-AE3A-88D1AA2D9B82

P577

Q33786737-38143A0C-F17E-4B6A-9B4A-43E6FF926B6E

P5875

Q33786737-614F90EC-C42C-4CEE-B804-A9089DF52183

P698

Q33786737-6E8180CF-16AB-466A-B628-306E4991FFA2

P921

Q33786737-FCD2D8DA-3165-4C3F-9CA3-46AD1B108E10

P932

Q33786737-FBB71915-5069-4F3D-B88E-8F733534AC0D

P356

P1433

Journal of Diabetes Research

P1476

Decreased plasma nesfatin-1 le ...... with type 2 diabetes mellitus

@en

P2093

Fangfang Liu

http://www.w3.org/2001/XMLSchema#string

Fupeng Liu

http://www.w3.org/2001/XMLSchema#string

Ning Gao

http://www.w3.org/2001/XMLSchema#string

Qing Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance

Identification of nesfatin-1 as a satiety molecule in the hypothalamus

Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism

Nesfatin-1 Exerts a Direct, Glucose-Dependent Insulinotropic Action on Mouse Islet Beta and MIN6 Cells

Increased Plasma Levels of Nesfatin-1 in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Regulation of food intake: the gastric X/A-like endocrine cell in the spotlight

The interface between thyroid and diabetes mellitus.

Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans.

Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.

P304

128014

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/128014

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263708057

http://www.w3.org/2001/XMLSchema#string

P698

24995340

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4065684

http://www.w3.org/2001/XMLSchema#string